RBC Capital markets adjusted their stance on Cochlear Ltd. (COH:AU) (OTC: CHEOY), a $10.9 billion medical device company ...

In a report released yesterday, Shagun Singh Chadha from RBC Capital reiterated a Buy rating on Dexcom (DXCM – Research Report), with a price ...

RBC Capital Markets adjusted its price target for Q2 Holdings stock, raising it to $108 from the previous $105, while maintaining a Sector Perform rating. The increase follows Q2 Holdings' report of ...

RBC Capital analyst Chris Dendrinos maintained a Buy rating on HASI (HASI – Research Report) yesterday and set a price target of $38.00. The ...

In this article, we are going to take a look at where International Business Machines Corporation (NYSE:IBM) stands against ...

Following a record year for catastrophe bond issuance in 2024, the cat bond market remains strong, and according to analysts ...

RBC Capital lowered the firm’s price target on PepsiCo (PEP) to $164 from $172 and keeps a Sector Perform rating on the ...

RBC Capital Markets analyst Bish Koziol made eight changes to his quantitatively driven top 40 list of stock picks. Maple ...

RBC Capital analyst Brian Abrahams says shares of Sarepta (SRPT) could be trading lower today on an FDA database update that included am Elevidys patient death, which occurred in November in a patient ...

It expresses the views and opinions of the author. A leading global investment bank and part of Royal Bank of Canada, RBC Capital Markets is recognized for its commitment to innovation ...

On Monday, RBC Capital Markets adjusted its stance on CAR Group (CAR:AU) (OTC: CSXXY), downgrading the stock from Outperform to Sector Perform and slightly reducing the price target to AUD39.00 ...